Assessment of Platelet Inhibition by Point-of-Care Testing in Neuroendovascular Procedures

被引：17
|
作者：
Hussein, H. M. [1 ]
Emiru, T. [1 ]
Georgiadis, A. L. [1 ]
Qureshi, A. I. [1 ]
机构：
[1] Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN 55455 USA
来源：
AMERICAN JOURNAL OF NEURORADIOLOGY | 2013年 / 34卷 / 04期
关键词：
PERCUTANEOUS CORONARY INTERVENTION; DUAL ANTIPLATELET THERAPY; VON-WILLEBRAND-DISEASE; FUNCTION ANALYZER; STENT THROMBOSIS; NEUROINTERVENTIONAL PROCEDURES; ACETYLSALICYLIC-ACID; ASPIRIN RESISTANCE; SHEAR-STRESS; REDUCED RISK;
D O I：
10.3174/ajnr.A2963
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Antiplatelet agents are an important component of the preventive strategies currently used in clinical practice to minimize the risk of thromboembolic events during and after endovascular procedures. Because of the variability in the response to antiplatelet agents, measuring the degree of platelet inhibition may help identify and properly treat poor responders. POC testing is defined as diagnostic testing at or near the site of patient care. Knowledge of the specifics of these devices among practicing neurointerventionalists is relatively limited. In this article, the different POC devices available are presented, and their clinical utility in relation to endovascular procedures is discussed.
引用
收藏
页码：700 / 706
页数：7
相关论文
共 50 条
  • [1] Point-of-Care Testing for Anticoagulation Monitoring in Neuroendovascular Procedures
    Hussein, H. M.
    Georgiadis, A. L.
    Qureshi, A. I.
    [J]. AMERICAN JOURNAL OF NEURORADIOLOGY, 2012, 33 (07) : 1211 - 1220
  • [2] Impact of Point-of-Care Platelet Function Testing by VerifyNow® on Periprocedural Antiplatelet Therapy in Neuroendovascular Stenting
    Noorian, Alireza
    Gupta, Rishi
    Wyatt, Katleen
    Nichols, Jessica
    Gershon, Raphael
    Nogueira, Raul
    [J]. NEUROLOGY, 2012, 78
  • [3] Point-of-Care Platelet Function Testing
    Harle, Christopher C.
    [J]. SEMINARS IN CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2007, 11 (04) : 247 - 251
  • [4] Outcomes assessment for point-of-care testing
    Rainey, PM
    [J]. CLINICAL CHEMISTRY, 1998, 44 (08) : 1595 - 1596
  • [5] A point-of-care assay allows rapid and accurate assessment of platelet inhibition by clopidogrel
    Good, R. I. S.
    McGarrity, A.
    Miller, H.
    Goodall, A. H.
    Oldroyd, K. G.
    [J]. SCOTTISH MEDICAL JOURNAL, 2007, 52 (04) : 47 - 47
  • [6] CytogeneticsPlatelet inhibition testing: whole blood point-of-care vs traditional platelet aggregometry
    Achram, Robert
    Barrette, Eileen
    Guarner, Jeannette
    Smith, Geoffrey
    Maier, Cheryl L.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S137 - S137
  • [7] CytogeneticsPlatelet inhibition testing: whole blood point-of-care vs traditional platelet aggregometry
    Shebelut, Conrad
    Stern, Julia
    Grewal, Sarah
    Smith, Geoffrey
    Jaye, David
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2023, 160 : S137 - S137
  • [8] The role of point-of-care platelet function testing in guiding platelet transfusion
    Bonhomme, F.
    [J]. TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2016, 23 (04) : 202 - 204
  • [9] Quality Assessment in Point-of-Care Coagulation Testing
    Kitchen, Dianne P.
    Kitchen, Steve
    Jennings, Ian
    Woods, Tim
    Walker, Isobel
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2008, 34 (07): : 647 - 653
  • [10] PIAST - Platelet Inhibition Assessment in Stroke Trial - The Assessment of Efficacy of Platelet Aggregation Inhibition in Stroke Patients with the Multiplate Analyzer, a Point-of-Care Method
    Menon, Sanjay
    Jun, Thomas
    Meyding-Lamade, Uta
    Grabowski, Andre
    [J]. NEUROLOGY, 2013, 80
12345